Citations for
1ADORA2A
Pharmacological blockade of adenosine A2A receptors diminishes scarring.
Perez-Aso M, Chiriboga L, Cronstein BN.
FASEB J 26(10):4254-63. doi: 10.1096/fj.12-209627. Epub 2012 Jul 5. 2012
2ADORA2A
A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.
Mills JH, Kim DG, Krenz A, Chen JF, Bynoe MS.
J Immunol 188(11):5713-22. doi: 10.4049/jimmunol.1200545. Epub 2012 Apr 23. 2012
3ADORA2A
Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease.
Kachroo A, Schwarzschild MA.
Ann Neurol 71(2):278-82. doi: 10.1002/ana.22630. 2012
4ADORA2A, CNR1
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.
Lazzerini PE, Natale M, Gianchecchi E, Capecchi PL, Montilli C, Zimbone S, Castrichini M, Balistreri E, Ricci G, Selvi E, Garcia-Gonzalez E, Galeazzi M, Laghi-Pasini F.
J Mol Med (Berl) 90(3):331-42. doi: 10.1007/s00109-011-0824-5. Epub 2011 Oct 28. 2012
5ADORA2A
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning.
Wei CJ, Singer P, Coelho J, Boison D, Feldon J, Yee BK, Chen JF.
Learn Mem 18(7):459-74. doi: 10.1101/lm.2136011. Print 2011. 2011
6ADORA2A
Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation.
Köröskényi K, Duró E, Pallai A, Sarang Z, Kloor D, Ucker DS, Beceiro S, Castrillo A, Chawla A, Ledent CA, Fésüs L, Szondy Z.
J Immunol 186(12):7144-55. doi: 10.4049/jimmunol.1002284. Epub 2011 May 18. 2011
7ADORA2A
Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction.
Rebola N, Simőes AP, Canas PM, Tomé AR, Andrade GM, Barry CE, Agostinho PM, Lynch MA, Cunha RA.
J Neurochem 117(1):100-11. doi: 10.1111/j.1471-4159.2011.07178.x. Epub 2011 Feb 9. 2011
8ADORA2A, CNR1
Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.
Martire A, Tebano MT, Chiodi V, Ferreira SG, Cunha RA, Köfalvi A, Popoli P.
J Neurochem 116(2):273-80. doi: 10.1111/j.1471-4159.2010.07101.x. Epub 2010 Dec 2. 2011
9ADORA2A, NTRK2
Role of adenosine A(2A) receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease.
Tebano MT, Martire A, Chiodi V, Ferrante A, Popoli P.
ScientificWorldJournal 10:1768-82. doi: 10.1100/tsw.2010.164. Review. 2010
10ADORA2A
DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain.
Buira SP, Dentesano G, Albasanz JL, Moreno J, Martín M, Ferrer I, Barrachina M.
J Neurochem 115(1):283-95. doi: 10.1111/j.1471-4159.2010.06928.x. Epub 2010 Aug 19. 2010
11ADORA2A
Adenosine A(2) receptors modulate tubuloglomerular feedback.
Carlström M, Wilcox CS, Welch WJ.
Am J Physiol Renal Physiol 299(2):F412-7. doi: 10.1152/ajprenal.00211.2010. Epub 2010 Jun 2. 2010
12ADORA2A
Adenosine A2A receptor expression in peripheral blood mononuclear cells of patients with mild cognitive impairment.
Arosio B, Viazzoli C, Mastronardi L, Bilotta C, Vergani C, Bergamaschini L.
J Alzheimers Dis 20(4):991-6. doi: 10.3233/JAD-2010-090814. 2010
13ADORA2A
Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma.
Kim SH, Kim YK, Park HW, Kim SH, Kim SH, Ye YM, Min KU, Park HS.
Respir Med 103(3):356-63. Epub 2008 Nov 18. 2009
14ADORA2A, HD
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.
Dhaenens CM, Burnouf S, Simonin C, Van Brussel E, Duhamel A, Defebvre L, Duru C, Vuillaume I, Cazeneuve C, Charles P, Maison P, Debruxelles S, Verny C, Gervais H, Azulay JP, Tranchant C, Bachoud-Levi AC, Dürr A, Buée L, Krystkowiak P, Sablonničre B, Blum D; Huntington French Speaking Network.
Neurobiol Dis 35(3):474-6. Epub 2009 Jul 8.PMID: 19591938 2009
15ADORA2A, EPAS1
Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.
Ahmad A, Ahmad S, Glover L, Miller SM, Shannon JM, Guo X, Franklin WA, Bridges JP, Schaack JB, Colgan SP, White CW.
Proc Natl Acad Sci U S A 106(26):10684-9. Epub 2009 Jun 17.PMID: 19541651 2009
16ADORA2A, HD
The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
Chiang MC, Chen HM, Lai HL, Chen HW, Chou SY, Chen CM, Tsai FJ, Chern Y.
Hum Mol Genet 18(16):2929-42. Epub 2009 May 14.PMID: 19443488 2009
17ADORA2A
Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.
Facheris MF, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Rocca WA, Maraganore DM.
Mov Disord 23(14):2033-40.PMID: 18759349 2008
18ADORA2A
Stable interactions between the transmembrane domains of the adenosine A2A receptor.
Thévenin D, Lazarova T.
Protein Sci 17(7):1188-99. Epub 2008 Apr 23.PMID: 18434504 2008
19ACTN1, ADORA2A, CYTH2, TSNAX, USP4
The A(2A)-adenosine receptor: a GPCR with unique features?
Zezula J, Freissmuth M.
Br J Pharmacol 153 Suppl 1:S184-90. Epub 2008 Feb 4. Review.PMID: 18246094 2008
20ADORA2A, ADORA2B, ADORA3
Distribution of adenosine receptors in human sclera fibroblasts.
Cui D, Trier K, Chen X, Zeng J, Yang X, Hu J, Ge J.
Mol Vis 14:523-9.PMID: 18385786 2008
21ADORA2A
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption.
Cornelis MC, El-Sohemy A, Campos H.
Am J Clin Nutr 86(1):240-4.PMID: 17616786 2007
22ADORA2A
Biological abnormalities of peripheral A(2A) receptors in a large representation of polyglutamine disorders and Huntington's disease stages.
Varani K, Bachoud-Lévi AC, Mariotti C, Tarditi A, Abbracchio MP, Gasperi V, Borea PA, Dolbeau G, Gellera C, Solari A, Rosser A, Naji J, Handley O, Maccarrone M, Peschanski M, DiDonato S, Cattaneo E.
Neurobiol Dis 27(1):36-43. Epub 2007 Apr 5.PMID: 17512749 2007
23ADORA2A, NECAB2
The neuronal Ca(2+) -binding protein 2 (NECAB2) interacts with the adenosine A(2A) receptor and modulates the cell surface expression and function of the receptor.
Canela L, Luján R, Lluís C, Burgueńo J, Mallol J, Canela EI, Franco R, Ciruela F.
Mol Cell Neurosci 36(1):1-12. Epub 2007 Jun 27.PMID: 17689978 2007
24ADORA2A, TSNAX
Rescue of p53 blockage by the A(2A) adenosine receptor via a novel interacting protein, translin-associated protein X.
Sun CN, Cheng HC, Chou JL, Lee SY, Lin YW, Lai HL, Chen HM, Chern Y.
Mol Pharmacol 70(2):454-66. Epub 2006 Apr 14. 2006
25ADORA2A
Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K.
Mol Pharmacol 67(2):400-7. Epub 2004 Nov 11. 2005
26ADORA2A
Oligomerization of the fifth transmembrane domain from the adenosine A2A receptor.
Thevenin D, Lazarova T, Roberts MF, Robinson CR.
Protein Sci 14(8):2177-86. Epub 2005 Jun 29. 2005
27ADORA2A, CYTH2
Heterotrimeric G protein-independent signaling of a G protein-coupled receptor. Direct binding of ARNO/cytohesin-2 to the carboxyl terminus of the A2A adenosine receptor is necessary for sustained activation of the ERK/MAP kinase pathway.
Gsandtner I, Charalambous C, Stefan E, Ogris E, Freissmuth M, Zezula J.
J Biol Chem 280(36):31898-905. Epub 2005 Jul 18. 2005
28ADORA2A
Oligomerization of adenosine A2A and dopamine D2 receptors in living cells.
Kamiya T, Saitoh O, Yoshioka K, Nakata H.
Biochem Biophys Res Commun 306(2):544-9. 2003
29ADORA2A, ADORA2B
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
Ohta A, Sitkovsky M.
Nature 414(6866):916-20. 2001
30ADORA2A, SCZD4
Mapping of the human adenosine A2a receptor gene : relationship to potential schizophrenia loci on chromosome 22q and exclusion from the CATCH 22 region.
Deckert J, et al.
Hum Genet 99 : 326-328. 1997
31ADORA2A, D11S1917, D11S2161E, GAL, RPL37P1, RPL37P2, RPL37P3
Framework YAC contig anchored into a 3.2-Mb high-resolution physical map in proximal 11q13.
Courseaux A, et al.
Genomics 40 : 13-23. 1997
32ADORA2A
Characterization and expression of the human A2a adenosine receptor gene.
Peterfreund RA, et al.
J Neurochem 66 : 362-368. 1996
33ADORA2A
Characterization and chromosomal localization of the human A2a adenosine receptor gene : ADORA2A.
Le F, et al.
Biochem Biophys Res Commun 223 : 461-467. 1996
34ADORA2A
Mapping of a human A2a adenosine receptor (ADORA2) to chromosome 22.
MacCollin M, et al.
Genomics 20 : 332-333. 1994
35ADORA2A
Molecular characterization of a human brain adenosine A2 receptor.
Furlong TJ, Pierce KD, Selbie LA, Shine J.
Brain Res Mol Brain Res 15(1-2):62-6.PMID: 1331670 1992
36ADORA1, ADORA2A, HTR1D
Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor.
Libert F, et al.
Genomics 11 : 225-227. 1991